Selective dicer suppression in the kidney alters gsk3β/β-Catenin Pathways Promoting a Glomerulocystic Disease

Anna Iervolino, Francesco Trepiccione, Federica Petrillo, Manuela Spagnuolo, Marzia Scarfò, Daniela Frezzetti, Gabriella De Vita, Mario De Felice, Giovambattista Capasso

Research output: Contribution to journalArticlepeer-review


Dicer is a crucial enzyme for the maturation of miRNAs. Mutations in the Dicer gene are highly associated with Pleuro Pulmonary Blastoma-Family Dysplasia Syndrome (PPB-FDS, OMIM 601200), recently proposed to be renamed Dicer syndrome. Aside from the pulmonary phenotype (blastoma), renal nephroma and thyroid goiter are frequently part of Dicer syndrome. To investigate the renal phenotype, conditional knockout (cKO) mice for Dicer in Pax8 expressing cells were generated. Dicer cKO mice progressively develop a glomerulocystic phenotype coupled with urinary concentration impairment, proteinuria and severe renal failure. Higher cellular turnover of the parietal cells of Bowman's capsule precedes the development of the cysts and the primary cilium progressively disappears with cyst-enlargement. Upregulation of GSK3β precedes the development of the glomerulocystic phenotype. Downregulation of β-catenin in the renal cortex and its cytosolic removal in the cells lining the cysts may be associated with observed accumulation of GSK3β. Alterations of β-catenin regulating pathways could promote cystic degeneration as in other models. Thus, miRNAs are fundamental in preserving renal morphology and function. Alteration of the GSK3β/β-catenin pathway could be a crucial mechanism linking miRNA dysregulation and the development of a glomerulocystic disease.

Original languageEnglish
Article numbere0119142
JournalPLoS One
Issue number3
Publication statusPublished - Mar 23 2015

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)


Dive into the research topics of 'Selective dicer suppression in the kidney alters gsk3β/β-Catenin Pathways Promoting a Glomerulocystic Disease'. Together they form a unique fingerprint.

Cite this